Brighter grows - recruits Arabic speaking project manager for market introduction of Actiste in the GCC region; and also strengthens the CFO office.

Brighter strengthens its marketing and sales team for the introduction of the company's unique Diabetes Solution Actiste® in the Middle East. The Gulf Cooperation Council (GCC) region has the fastest increase in diabetes in the world and the disease has a high priority in many of the region's countries.

“13% of the citizens in the United Arab Emirates have diabetes today and the populations share of diabetics is expected to double by 2045. In Kuwait, 10% of the population have diabetes and the proportion is expected to increase by 125% by 2045. It is an incredibly interesting market to enter not only because the patient base is large, but also because the health care sector in the region really wants to create the world's most modern care and thus crave new, resource-efficient therapies,” says Brighter's founder and CEO Truls Sjöstedt.

Brighter announced in July this year that the Company plans to start a joint venture with AFAQ Group L.L.C, located in the United Arab Emirates, to gain local presence in the region. However, the position of the project manager that is now announced will be based in Stockholm. The applicant should be a driven and independent project manager in a marketing or sales organization and have experience from working in the GCC region, as well as ability to speak, read and write Arabic, Swedish and English.

Brighter also recruits an accounting economist to strengthen the finance department for the planned change of listing to a regulated market, and for future expansion.

About Actiste

Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injection, and automatic logging and timing of all activity are done in a single unit. Actiste is connected via an autonomous and secure mobile connection, the information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed.

Validated user-generated data, such as glucose levels or insulin doses, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. www.actiste.com

About Brighter AB (publ)

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole.

The Company's shares are listed on NASDAQOMX First North/BRIG.

Visit our website and subscribe to press releases: www.brighter.se

Follow us on:

www.introduce.se

Certified Adviser

Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.

For further information, please contact: